Trending...
- California: Governor Newsom, Superintendent Thurmond announce over $618 million to support another 458 community schools
- $4.3 Million Patent Application Waiver Fee Granted by FDA on New Drug Application Fee for Treatment Addressing Suicidal Depression & PTSD: NRX Pharma
- xREnergy up as much as +3,094,634% on first day listed on the XRP Ledger. Ticker : $XRE
PALO ALTO, Calif., April 11, 2023 ~ Glooko Inc. and Hedia have announced a new global partnership, integrating Hedia's technology into Glooko's diabetes management platforms for healthcare providers and people with diabetes. The collaboration will provide an interoperable solution that brings together connected care, remote patient monitoring and digital therapeutic technologies to enhance access for people with Type 1 and Type 2 diabetes requiring bolus insulin dosing advice.
The Glooko platforms allow patients to share their diabetes data with their healthcare providers (HCPs), including blood glucose readings, insulin doses, food and carbs, exercise activity, blood pressure and weight. With the integration of Hedia Diabetes Assistant, people with diabetes will be able to receive bolus insulin dosing advice which will provide personalized care and reduce the burden of manually calculating required insulin doses. In addition, when used in conjunction with connected insulin pens*, the integrated solution facilitates a high level of visibility for HCPs who are managing patients on multiple daily injection (MDI) therapy. This integration enhances the capabilities of Glooko's remote patient monitoring (RPM) and supports virtual consultations for MDI patients.
More on The Californer
Glooko CEO Russ Johannesson expressed his pleasure at the partnership saying "We are very pleased to partner with Hedia to offer this algorithm-driven innovation for personalized healthcare for diabetes patients and their healthcare teams. The robust clinical data supporting Hedia's efficacy demonstrates this could be a viable alternative for patients who are not able to access insulin pumps. This partnership shows how interoperability gives people with diabetes the optimal tools available to ease the management of their condition and enhance health outcomes such as the stability of blood glucose levels."
Hedia CEO Peter Lucas also commented on the partnership saying "We are thrilled to call Glooko, a company with such an extensive clinical network, our partner in digital health. In addition to our strong clinical evidence, one of the key issues we consider when building our technology is regulatory compliance and cybersecurity. Glooko has demonstrated their strength in these areas with multiple third-party certifications and that's a key driver behind our partnership. Hedia's Class IIb medical device designation ensures that the best solutions are being provided to patients and their care teams."
More on The Californer
The initial European launch of the integration is expected in late 2023 or early 2024*.
This new collaboration between Glooko Inc. and Hedia promises improved access for people with Type 1 or Type 2 diabetes requiring bolus insulin dosing advice through an interoperable solution that brings together connected care, remote patient monitoring and digital therapeutic technologies. With this integration comes enhanced capabilities for both healthcare providers managing MDI therapy as well as virtual consultations for MDI patients while providing personalized care through bolus insulin dosing advice which reduces manual calculations required by those living with diabetes.*The connected pen feature is available only in the EU
The Glooko platforms allow patients to share their diabetes data with their healthcare providers (HCPs), including blood glucose readings, insulin doses, food and carbs, exercise activity, blood pressure and weight. With the integration of Hedia Diabetes Assistant, people with diabetes will be able to receive bolus insulin dosing advice which will provide personalized care and reduce the burden of manually calculating required insulin doses. In addition, when used in conjunction with connected insulin pens*, the integrated solution facilitates a high level of visibility for HCPs who are managing patients on multiple daily injection (MDI) therapy. This integration enhances the capabilities of Glooko's remote patient monitoring (RPM) and supports virtual consultations for MDI patients.
More on The Californer
- Poll Finds Overwhelming Opposition to Keeping Big Cats as Pets
- SM Telecom Expands AT&T Partnership to Deliver Cutting-Edge 5G+ Wireless Solutions New Collab Brings AT&T's Advanced 5G+ Technology to Cellphone
- Governor Newsom proclaims Older Californians Month
- Groundbreaking Launches 154-Acre Los Cerritos Wetlands Restoration in Long Beach – Single Largest Increase in Open Space in Long Beach in Decades
- Don Barnhart Drops Unapologetically Hilarious Comedy Special "You Do You," On Open Bar Network
Glooko CEO Russ Johannesson expressed his pleasure at the partnership saying "We are very pleased to partner with Hedia to offer this algorithm-driven innovation for personalized healthcare for diabetes patients and their healthcare teams. The robust clinical data supporting Hedia's efficacy demonstrates this could be a viable alternative for patients who are not able to access insulin pumps. This partnership shows how interoperability gives people with diabetes the optimal tools available to ease the management of their condition and enhance health outcomes such as the stability of blood glucose levels."
Hedia CEO Peter Lucas also commented on the partnership saying "We are thrilled to call Glooko, a company with such an extensive clinical network, our partner in digital health. In addition to our strong clinical evidence, one of the key issues we consider when building our technology is regulatory compliance and cybersecurity. Glooko has demonstrated their strength in these areas with multiple third-party certifications and that's a key driver behind our partnership. Hedia's Class IIb medical device designation ensures that the best solutions are being provided to patients and their care teams."
More on The Californer
- Cygnet Theatre Announces The Cast and Creative Team of Rodgers and Hammerstein's Oklahoma!
- Shon Garage Door Repair Expands Trusted Services to San Diego, CA
- Nicky Dare Honors Indonesian Heritage at VAPI–Valley Asian and Pacific Islanders Cultural Festival
- California launches new AI-powered chatbot that provides wildfire resources in 70 languages
- Summit Startup Solutions Launches Innovative, Flexible Support Services for Startups
The initial European launch of the integration is expected in late 2023 or early 2024*.
This new collaboration between Glooko Inc. and Hedia promises improved access for people with Type 1 or Type 2 diabetes requiring bolus insulin dosing advice through an interoperable solution that brings together connected care, remote patient monitoring and digital therapeutic technologies. With this integration comes enhanced capabilities for both healthcare providers managing MDI therapy as well as virtual consultations for MDI patients while providing personalized care through bolus insulin dosing advice which reduces manual calculations required by those living with diabetes.*The connected pen feature is available only in the EU
Filed Under: Business
0 Comments
Latest on The Californer
- California: Governor Newsom issues statement on Pope Leo XIV, the first American Pope
- New poll shows high rates of employee burnout amid concerns over politics and personal finances
- Tessellations Appoints Luthern Williams as Head of School
- Aureli Construction Sets the Standard for Seamless Home Additions in Greater Boston
- Psychological Thriller "Killing Off Connor" To Open 34th IFS Film Fest After 12-years In Post
- Harvest Properties Acquires Two San Francisco Bay Area Self Storage Facilities for $44.2 Million
- California businesses in near-universal compliance with prohibition of intoxicating hemp products harmful to youth
- California: Governor Newsom announces upgrades to 21 state fish hatcheries to boost salmon populations
- Solaris Energy Infrastructure, Inc. (SEI) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
- Risk Rater, Threat Assessment App, gives Users the Same Threat Evaluation as the Rich and Powerful
- Is it Really True That Tariffs Will Raise Car Insurance Rates?
- ScreenPoints Puts Film Investors in the Credits—and in the Money With New FinTech Platform
- Coastal Business Systems Wraps Up Successful 2025 Tech Show in Redding
- AdOcto Turns AirBnBs Into High-Impact Advertising Channels
- Zefr Announces Launch of Pre-Screen Brand Safety Solution for Google's Search Partner Network (SPN)
- Pathways to Adulthood Conference May 17 at Melville Marriott Honoring NYS Assembly Member Jodi Giglio, Suffolk County Legislator Nick Caracappa
- Adster Techologies awarded US Patent for breakthrough innovation in reducing latency in Ad Serving
- Flexi-View Lending Closes $5.05 Million Residential Acquisition Loan in Billings, Montana
- Robert Fabbio Inducted into the Austin Technology Council Hall of Fame
- California: Governor Newsom, Superintendent Thurmond announce over $618 million to support another 458 community schools